Clinical pathways to diagnose melanoma: A population-based study

Melanoma Research

Volumn 17, Issue 4, 2007, Pages 243-249

  Baade, Peter D ^a,b   Youl, Philippa H ^a   English, Dallas R ^a   Elwood, J Mark ^a   Aitken, Joanne F ^a  

^a CANCER COUNCIL QUEENSLAND   (Australia)

^b NONE   (Australia)

Author keywords

Diagnosis; Diagnostic pathway; Early detection; General practitioner; Melanoma; Physician

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER REGISTRY; CLINICAL PATHWAY; CONSULTATION; DERMATOLOGY; DESCRIPTIVE RESEARCH; FEMALE; GENERAL PRACTITIONER; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT REFERRAL; POPULATION RESEARCH; PRIORITY JOURNAL; ROLE PLAYING; RURAL AREA; SURGEON; URBAN AREA;

ADULT; AGED; BIOPSY; CRITICAL PATHWAYS; DERMATOLOGY; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PRIMARY HEALTH CARE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 34447567064     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328194f265     Document Type: Article

References (27)

1. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer 2003; 98:1223-1231.
2. Luke CG, Coventry BJ, Foster-Smith EJ, Roder DM. A critical analysis of reasons for improved survival from invasive cutaneous melanoma. Cancer Causes Control 2003; 14:871-878.
3. Hersey P. Adjuvant therapy for high-risk primary and resected metastatic melanoma. Int Med J 2003; 33:33-43.
4. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004; 351:998-1012.
5. Eggermont AMM. European approach to the treatment of malignant melanoma. Curr Opin Oncol 2002; 14:205-211.
6. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
7. Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 2000; 18:3782-3793.
8. Helsing P, Faye R, Langmark F. Cutaneous malignant melanoma. Correlation between tumour characteristics and diagnostic delay in Norwegian patients. Eur J Dermatol 1997; 7:359-361.
9. Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkenstein P, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000; 89:271-279.
10. Carli P, De Giorgi V, Palli D. Dermatologist detection and skin self examination are associates with thinner melanomas. Arch Dermatol 2003; 139:607-612.
11. Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkenstein P, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 2000; 89:280-285.
12. Schmid-Wendter M, Baumert J, Stange J, Volkenendt M. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res 2002; 12:389-394.
13. Baade PD, English DR, Youl PH, McPherson M, Elwood JM, Aitken JF. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol 2006; 142:1422-1427.
14. Cassileth BR, Temoshok L, Federick BE, Walsh WP, Hurwitz S, Guerry D, et al. Patient and physician delay in melanoma diagnosis. J Am Acad Dermatol 1988; 18:591-598.
15. Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkenstein P, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 2000; 89:280-285.
16. Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Time delays and related factors in the diagnosis of cutaneous melanoma. Eur J Cancer 2001; 37:843-848.
17. Blum A, Brand CU, Ellwanger U, Schlagenhauff B, Stroebel W, Rassner G, et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol 1999; 141:783-787.
18. McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 2006; 54:783-792.
19. AIHW Rural, regional and remote health: a guide to remoteness classifications. In Canberra, Australian Institute of Health and Welfare AIHW Cat. No. PHE 53, 2004.
20. Moffatt CR, Green AC, Whiteman DC. Diagnostic accuracy in skin cancer clinics: the Australian experience. Int J Dermatol 2006; 45:656-660.
21. Osborne JE, Chave TA, Hutchinson PE. Comparison of diagnostic accuracy for cutaneous malignant melanoma between general dermatology, plastic surgery and pigmented lesion clinics. Br J Dermatol 2003; 148:252-258.
22. Carli P, De Giorgi V, Betti R, Vergani R, Catricala C, Mariani G, et al. Relationship between cause of referral and diagnostic outcome in pigmented lesion clinics: a multicentre survey of the Italian Multidisciplinary Group on Melanoma (GIPMe). Melanoma Res 2003; 13:207-211.
23. SAS Institute Inc. SAS OnlineDoc, Version 9.1.2. Cary, North Carolina, SAS Institute Inc., 2004.
24. Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C, et al. Self-detected cutaneous melanomas in Italian patients. Clin Exp Dermatol 2004; 29:593-596.
25. Coory M, Smithers M, Aitken J, Baade P, Ring I. Urban-rural differences in survival from cutaneous melanoma in Queensland. Aust NZ J Public Health 2006; 30:71-74.
26. Rees JL. The melanoma epidemic: reality and artefact. BMJ 1996; 312:137-138.
27. Coory M, Baade PD, Aitken JF, Smithers M, McLeod GRC, Ring I. Trends for in-situ and invasive melanoma in Queensland, Australia, 1982 to 2002. Cancer Causes Control 2006; 17:21-27.